Key Developments: Towers Watson & Co (TW)

TW on New York Consolidated

106.01USD
24 Oct 2014
Price Change (% chg)

$0.53 (+0.50%)
Prev Close
$105.48
Open
$105.58
Day's High
$106.12
Day's Low
$104.68
Volume
286,930
Avg. Vol
490,902
52-wk High
$131.73
52-wk Low
$98.10

Search Stocks

Latest Key Developments (Source: Significant Developments)

Towers Watson & Co announces authorization to repurchase shares and increase to regular quarterly dividend
Friday, 22 Aug 2014 05:00pm EDT 

Towers Watson & Co:Approves the purchase of up to $300 million of the company's class A common stock and has terminated the existing share repurchase authorizations.Says it also approved a regular quarterly cash dividend of $0.15 per common share for the quarter ended June 30, 2014.Dividend is payable on or about Oct. 15 to stockholders of record at the close of business on Sept. 30.  Full Article

Towers Watson & Co gives Q1 2015 guidance in line with analysts' estimates
Tuesday, 12 Aug 2014 06:00am EDT 

Towers Watson & Co:Expects Q1 2015 revenues in range of $840 mln to $860 mln, reflecting constant currency revenue growth in range of 2 pct. to 5 pct.Expects Q1 2015 adjusted diluted earnings per share (EPS) in range of $1.17 to $1.22.Q1 2015 revenue of $856 mln and EPS of $1.18 - Thomson Reuters I/B/E/S.  Full Article

Towers Watson & Co announces regular quarterly dividend
Wednesday, 14 May 2014 01:46pm EDT 

Towers Watson & Co:Approves regular quarterly cash dividend of $0.14 per common share for quarter ended March 31, 2014.Dividend is payable on or about July 15, 2014 to stockholders of record at close of business on June 30, 2014.  Full Article

Towers Watson & Co gives lowers FY 2014 revenue guidance; raises FY 2014 EPS guidance; gives Q4 2014 guidance below analysts' estimates
Tuesday, 6 May 2014 06:00am EDT 

Towers Watson & Co:Expects FY 2014 revenues in range of $3.45 bln and adjusted diluted earnings per share (EPS) in range of $5.65 to $5.70.Expects Q4 2014 revenues in range of $840 mln to $855 mln.Expects Q4 2014 adjusted diluted earnings per share (EPS) in range of $1.23 to $1.28.FY 2014 revenue of $3.50 bln and EPS of $5.63 - Thomson Reuters I/B/E/S.Q4 2014 revenue of $882 mln and EPS of $1.33 - Thomson Reuters I/B/E/S.  Full Article

Towers Watson & Co teams with Segal Group to Expand access to medicare exchange
Wednesday, 2 Apr 2014 05:05pm EDT 

Towers Watson & Co:Nonexclusive agreement with Segal Group to expand access to private Medicare solution on Towers Watson's OneExchange.Segal will offer OneExchange as prequalified option to clients seeking private exchange solution for their Medicare-eligible retirees.  Full Article

Towers Watson & Co announces regular quarterly dividend
Tuesday, 18 Feb 2014 01:07pm EST 

Towers Watson & Co:Says that its Board of Directors approved a regular quarterly cash dividend of $0.14 per common share for the quarter ended Dec. 31, 2013.Dividend is payable on or about Apr. 15 to stockholders of record at the close of business on Mar. 31.  Full Article

Towers Watson & Co updates on FY 2014 revenue guidance; lowers FY 2014 EPS guidance; gives Q3 2014 revenue guidance below analysts' estimates; gives Q3 2014 EPS guidance above analysts' estimates
Thursday, 6 Feb 2014 06:00am EST 

Towers Watson & Co:Expects FY 2014 revenues in the range of $3.5 billion.Adjusted diluted earnings per share in the range of $5.55 to $5.65.The guidance assumes an average exchange rate of 1.61 U.S. dollars to the British Pound and 1.36 U.S. dollars to the Euro for FY 2014.FY 2014 revenues of $3.5 bln and EPS of $5.69 - Thomson Reuters I/B/E/S.Expects Q3 2014 revenues in the range of $915 to $925 million, reflecting constant currency revenue growth in the low single digits.Adjusted diluted earnings per share in the range of $1.45 to $1.50.Q3 2014 revenues of $933 mln and EPS of $1.39 - Thomson Reuters I/B/E/S.  Full Article

Towers Watson and Co announces expansion of exchange solutions segment
Thursday, 23 Jan 2014 08:00am EST 

Towers Watson and Co:Says it plans to unite the company-wide expertise and resources dedicated to health care exchanges and administration within its Exchange Solutions segment.Says it will combine the operations and associates of Extend Health, Liazon, much of its North American Technology and Administration Solutions health care business, and other consultants dedicated to health care exchanges into the existing Exchange Solutions segment.  Full Article

Towers Watson and Co Acquires Liazon To Expand Private Benefit Exchange Offerings Through Multiple Channels
Friday, 22 Nov 2013 08:00am EST 

Towers Watson and Co announced that it has acquired Liazon Corporation, a developing and delivering private benefit exchanges for active employees. The acquisition, which follows the purchase of Extend Health in June 2012, solidifies Towers Watson`s strength in the private exchange market through its OneExchange solution. The purchase price is $215 million, with the acquisition anticipated to be dilutive to adjusted EPS by approximately $0.10 to $0.15 in fiscal year 2014. There is no impact to the forecasted EBITDA margins. More information will be provided during a call for investors on November 25, 2013.  Full Article

Towers Watson and Co Announces Regular Quarterly Dividend Increase
Friday, 15 Nov 2013 05:23pm EST 

Towers Watson and Co that its Board of Directors approved a regular quarterly cash dividend of $0.14 per common share for the quarter ended September 30, 2013. This represents a 22% increase. The dividend is payable on or about January 15, 2014 to stockholders of record at the close of business on December 31, 2013.  Full Article

MOVES- BNP Paribas, Schroders, Towers Watson, Pimco

(Adds BNP Paribas, Pimco, Anglo American and Fifth Street)

Search Stocks